• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Effective implementation of the Accelerate Pheno™ system for positive blood cultures.有效实施 Accelerate Pheno™ 系统进行阳性血培养。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i40-i43. doi: 10.1093/jac/dky534.
2
Performance of the Accelerate Pheno™ system for identification and antimicrobial susceptibility testing of a panel of multidrug-resistant Gram-negative bacilli directly from positive blood cultures.Accelerate Pheno™ 系统在直接从阳性血培养物中鉴定和进行多药耐药革兰氏阴性杆菌药敏试验方面的性能。
J Antimicrob Chemother. 2018 Jun 1;73(6):1546-1552. doi: 10.1093/jac/dky032.
3
Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections.评估 Accelerate Pheno™ 系统在血流感染中快速鉴定和进行革兰氏阴性菌抗菌药物敏感性试验的性能。
Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1573-1583. doi: 10.1007/s10096-018-3287-6. Epub 2018 May 28.
4
Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact.易感性供应增强有效降级(SPEED):在革兰氏阴性菌血流感染中利用快速表型药敏试验及其潜在的临床影响。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i16-i23. doi: 10.1093/jac/dky531.
5
Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system.采用 Accelerate PhenoTM 系统对血培养阳性标本中的革兰阳性菌和革兰阴性菌进行鉴定和药敏试验。
Eur J Clin Microbiol Infect Dis. 2020 Jan;39(1):139-149. doi: 10.1007/s10096-019-03703-y. Epub 2019 Oct 22.
6
Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method.血培养分离病原体的药敏试验:Accelerate Pheno™ 与 VITEK® 2 系统与肉汤微量稀释法的性能比较。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i24-i31. doi: 10.1093/jac/dky532.
7
The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification.在一个已经建立了抗菌药物管理计划、目前正在利用快速基因分型生物体/耐药标志物识别的机构中,Accelerate Pheno™ 系统对有效治疗时间和确定性治疗时间的假设影响。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i32-i39. doi: 10.1093/jac/dky533.
8
Systematic Evaluation of the Accelerate Pheno System for Susceptibility Testing of Gram-Negative Bacteria Isolated from Blood Cultures.系统评估 Accelerate Pheno 系统对血培养分离的革兰氏阴性菌进行药敏试验的效果。
Microbiol Spectr. 2021 Dec 22;9(3):e0183621. doi: 10.1128/Spectrum.01836-21.
9
Rapid and cost-effective identification and antimicrobial susceptibility testing in patients with Gram-negative bacteremia directly from blood-culture fluid.直接从血培养液中对革兰氏阴性菌血症患者进行快速且经济高效的鉴定及抗菌药敏试验。
J Microbiol Methods. 2018 Mar;146:7-12. doi: 10.1016/j.mimet.2018.01.012. Epub 2018 Feb 3.
10
Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST.
BMC Microbiol. 2019 Nov 29;19(1):268. doi: 10.1186/s12866-019-1654-9.

引用本文的文献

1
Label-free rapid antimicrobial susceptibility testing with machine-learning based dynamic holographic laser speckle imaging.基于机器学习的动态全息激光散斑成像的无标记快速抗菌药敏试验
Biosens Bioelectron. 2025 Jun 15;278:117312. doi: 10.1016/j.bios.2025.117312. Epub 2025 Feb 25.
2
Clinical impact of the accelerate PhenoTest® BC system on patients with gram-negative bacteremia and high risk of antimicrobial resistance: a prospective before-after implementation study.Accelerate PhenoTest® BC 系统对革兰氏阴性菌血症且存在高抗菌药物耐药风险患者的临床影响:一项前瞻性实施前后研究。
Ann Clin Microbiol Antimicrob. 2023 Jul 29;22(1):62. doi: 10.1186/s12941-023-00619-6.
3
Contemporary Considerations for Establishing Reference Methods for Antibacterial Susceptibility Testing.建立抗菌药物敏感性试验参考方法的当代思考。
J Clin Microbiol. 2023 Jun 20;61(6):e0188622. doi: 10.1128/jcm.01886-22. Epub 2023 Mar 27.
4
Antimicrobial susceptibility testing for Gram positive cocci towards vancomycin using scanning electron microscopy.使用扫描电子显微镜对革兰氏阳性球菌进行针对万古霉素的药敏试验。
Curr Res Microb Sci. 2022 Jul 2;3:100154. doi: 10.1016/j.crmicr.2022.100154. eCollection 2022.
5
Rapid Antibiotic Susceptibility Testing of Tier-1 Agents , , and Directly From Whole Blood Samples.对一级药物以及直接从全血样本中进行快速抗生素敏感性测试。 (原文中“Tier-1 Agents”后面两个逗号位置不太对,推测可能是有遗漏信息,但按照要求仅做翻译)
Front Microbiol. 2021 Jul 9;12:664041. doi: 10.3389/fmicb.2021.664041. eCollection 2021.
6
Rapid Methods for Antimicrobial Resistance Diagnostics.抗菌药物耐药性诊断的快速方法
Antibiotics (Basel). 2021 Feb 20;10(2):209. doi: 10.3390/antibiotics10020209.
7
Impact of an Antimicrobial Stewardship Program-bundled initiative utilizing Accelerate Pheno™ system in the management of patients with aerobic Gram-negative bacilli bacteremia.抗菌药物管理项目捆绑式举措对革兰氏阴性需氧菌菌血症患者管理中利用 Accelerate Pheno™ 系统的影响。
Infection. 2021 Jun;49(3):511-519. doi: 10.1007/s15010-021-01581-1. Epub 2021 Feb 2.
8
Current state of the art in rapid diagnostics for antimicrobial resistance.当前抗菌药物耐药性快速诊断技术的现状。
Lab Chip. 2020 Aug 7;20(15):2607-2625. doi: 10.1039/d0lc00034e. Epub 2020 Jul 9.
9
A Multiplex Fluidic Chip for Rapid Phenotypic Antibiotic Susceptibility Testing.一种用于快速表型抗生素药敏试验的多重流控芯片。
mBio. 2020 Feb 25;11(1):e03109-19. doi: 10.1128/mBio.03109-19.

本文引用的文献

1
Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact.易感性供应增强有效降级(SPEED):在革兰氏阴性菌血流感染中利用快速表型药敏试验及其潜在的临床影响。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i16-i23. doi: 10.1093/jac/dky531.
2
Impact of antimicrobial therapy on the gut microbiome.抗菌治疗对肠道微生物组的影响。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i6-i15. doi: 10.1093/jac/dky530.
3
The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification.在一个已经建立了抗菌药物管理计划、目前正在利用快速基因分型生物体/耐药标志物识别的机构中,Accelerate Pheno™ 系统对有效治疗时间和确定性治疗时间的假设影响。
J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i32-i39. doi: 10.1093/jac/dky533.
4
A Prospective Evaluation of Two Rapid Phenotypical Antimicrobial Susceptibility Technologies for the Diagnostic Stewardship of Sepsis.两种快速表型抗菌药物敏感性技术用于脓毒症诊断管理的前瞻性评估。
Biomed Res Int. 2018 May 10;2018:6976923. doi: 10.1155/2018/6976923. eCollection 2018.
5
The Cost-Effectiveness of Rapid Diagnostic Testing for the Diagnosis of Bloodstream Infections with or without Antimicrobial Stewardship.快速诊断检测在有或没有抗菌药物管理的情况下用于诊断血流感染的成本效益。
Clin Microbiol Rev. 2018 May 30;31(3). doi: 10.1128/CMR.00095-17. Print 2018 Jul.
6
Evaluation of the Accelerate Pheno™ system for rapid identification and antimicrobial susceptibility testing of Gram-negative bacteria in bloodstream infections.评估 Accelerate Pheno™ 系统在血流感染中快速鉴定和进行革兰氏阴性菌抗菌药物敏感性试验的性能。
Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1573-1583. doi: 10.1007/s10096-018-3287-6. Epub 2018 May 28.
7
Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.哌拉西林他唑巴坦或美罗培南联合万古霉素治疗患者急性肾损伤的发生率。
Antimicrob Agents Chemother. 2018 Jun 26;62(7). doi: 10.1128/AAC.00264-18. Print 2018 Jul.
8
Accelerate PhenoTest BC Kit Versus Conventional Methods for Identification and Antimicrobial Susceptibility Testing of Gram-Positive Bloodstream Isolates: Potential Implications for Antimicrobial Stewardship.加速PhenoTest BC试剂盒与传统方法用于革兰氏阳性血流分离株的鉴定和抗菌药物敏感性测试:对抗菌药物管理的潜在影响
Ann Pharmacother. 2018 Aug;52(8):754-762. doi: 10.1177/1060028018765486. Epub 2018 Mar 20.
9
Antibiotic Use in the Intensive Care Unit: Optimization and De-Escalation.抗生素在重症监护病房的应用:优化与降级。
J Intensive Care Med. 2018 Dec;33(12):647-655. doi: 10.1177/0885066618762747. Epub 2018 Mar 13.
10
Performance of the Accelerate Pheno™ system for identification and antimicrobial susceptibility testing of a panel of multidrug-resistant Gram-negative bacilli directly from positive blood cultures.Accelerate Pheno™ 系统在直接从阳性血培养物中鉴定和进行多药耐药革兰氏阴性杆菌药敏试验方面的性能。
J Antimicrob Chemother. 2018 Jun 1;73(6):1546-1552. doi: 10.1093/jac/dky032.

有效实施 Accelerate Pheno™ 系统进行阳性血培养。

Effective implementation of the Accelerate Pheno™ system for positive blood cultures.

机构信息

Accelerate Diagnostics, Inc., Tucson, AZ, USA.

Accelerate Diagnostics S.L., Barcelona, Spain.

出版信息

J Antimicrob Chemother. 2019 Jan 1;74(Suppl 1):i40-i43. doi: 10.1093/jac/dky534.

DOI:10.1093/jac/dky534
PMID:30690541
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6382030/
Abstract

Using conventional methods, organism identification (ID) and antibiotic susceptibility testing (AST) results are available ∼1.5-3 days after positive blood culture. New technologies can reduce this time to 8-12 h, allowing therapy to be optimized substantially sooner. To make full use of fast ID and AST results requires overcoming various hurdles to effective implementation, including restructuring laboratory workflows to optimize timeliness of results and modifying clinical pathways to respond more quickly when results are available. Efficient laboratory procedures and clinical interventions coupled with fast and accurate identification and AST results have the potential to substantially reduce overall costs and provide more-sophisticated and effective patient management.

摘要

采用常规方法,阳性血培养后约 1.5-3 天可获得微生物鉴定 (ID) 和抗生素药敏试验 (AST) 结果。新技术可将这一时间缩短至 8-12 小时,从而大幅提前优化治疗。为充分利用快速 ID 和 AST 结果,需要克服各种障碍以实现有效实施,包括重构实验室工作流程以优化结果的及时性,并在结果可用时修改临床路径以更快地做出响应。有效的实验室程序和临床干预措施,加上快速准确的 ID 和 AST 结果,有可能大幅降低总体成本,并提供更复杂和有效的患者管理。